Crossmark

The effect of Edaravone on acute ischemic stroke, large vessel occlusion, not treated with intravenous thrombolytic, and endovascular thrombectomy: a double-blind placebo-controlled trial

Crossref DOI link: https://doi.org/10.1007/s00210-025-04622-w

Published Online: 2025-10-24

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Razmeh, Saeed

Dashti, Amir Mohammad

Roustaie, Narges

larki, Rozina Abbasi

Habibi, Amir Hassan
License Information

Text and Data Mining valid from 2025-10-24

Version of Record valid from 2025-10-24
More Information

Article History

Received: 10 June 2025

Accepted: 3 September 2025

First Online: 24 October 2025

Declarations

:

: The protocol of this study was approved by the Institutional Ethics Committee of Yasuj University of Medical Sciences (ethical code: IR.YUMS.REC.1402.157). This study wasregistered in the Iranian Registry of Clinical Trials (registration number: IRCT20240224061102N1).

: Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below